Marine Drugs (Jul 2019)

Antagonism of Quorum Sensing Phenotypes by Analogs of the Marine Bacterial Secondary Metabolite 3-Methyl-<i>N</i>-(2′-Phenylethyl)-Butyramide

  • Susan M. Meschwitz,
  • Margaret E. Teasdale,
  • Ann Mozzer,
  • Nicole Martin,
  • Jiayuan Liu,
  • Stephanie Forschner-Dancause,
  • David C. Rowley

DOI
https://doi.org/10.3390/md17070389
Journal volume & issue
Vol. 17, no. 7
p. 389

Abstract

Read online

Quorum sensing (QS) antagonists have been proposed as novel therapeutic agents to combat bacterial infections. We previously reported that the secondary metabolite 3-methyl-N-(2′-phenylethyl)-butyramide, produced by a marine bacterium identified as Halobacillus salinus, inhibits QS controlled phenotypes in multiple Gram-negative reporter strains. Here we report that N-phenethyl hexanamide, a structurally-related compound produced by the marine bacterium Vibrio neptunius, similarly demonstrates QS inhibitory properties. To more fully explore structure−activity relationships within this new class of QS inhibitors, a panel of twenty analogs was synthesized and biologically evaluated. Several compounds were identified with increased attenuation of QS-regulated phenotypes, most notably N-(4-fluorophenyl)-3-phenylpropanamide against the marine pathogen Vibrio harveyi (IC50 = 1.1 µM). These findings support the opportunity to further develop substituted phenethylamides as QS inhibitors.

Keywords